Oppenheimer & Co’s RXO RXO Stock Holding History
Bought
Maintained
Sold
Other funds holding RXO
MP
Oppenheimer & Co's RXO Position: Q3 2026 in Review
Oppenheimer & Co sold out of RXO (RXO) in Q3 2026, closing a stake of 48,030 shares — an estimated $1.33M sold.
Oppenheimer & Co first reported a position in RXO in Q4 2022 and held it in 15 quarters. The position peaked at $1.56M in Q1 2023. 307 funds tracked by Wall St. Rank hold RXO as of Q3 2026.
- Oppenheimer & Co reported no remaining RXO position as of Q3 2026 after selling out during the quarter.
- Oppenheimer & Co sold 48,030 RXO shares in Q3 2026, an estimated $1.33M.
- Oppenheimer & Co first reported a position in RXO in Q4 2022 and held it in 15 quarters.
- Oppenheimer & Co's RXO position peaked at $1.56M in Q1 2023.
- 307 funds tracked by Wall St. Rank held RXO as of Q3 2026.
Based on Oppenheimer & Co's 13F filing for Q3 2026, filed 26 Oct 2026.